Clinical trial
Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes
NCT00401297 · Yale University, Other · Completed
Key facts
| NCT number | NCT00401297 |
|---|---|
| Title | Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes |
| Official title | Intervenable Host- Leishmania (Vianna) Interactions Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection Aim 1: To Determine if Th1/Th2 Polarization Occurs and is Linked to the Outcome of Infection by L. Viannia |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leishmaniasis |
| Enrollment | 122 |
| Start date | Dec 1, 2006 |
| Completion | Apr 1, 2010 |
| First posted | Nov 20, 2006 |
| Last update posted | Mar 30, 2020 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: